News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Bhavina Sharma MD

Articles by Bhavina Sharma MD

This trial combines pembrolizumab and trabedersen to enhance treatment for advanced NSCLC, targeting TGF-β2 for improved patient outcomes.

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC

ByOmar K. Abughanimeh, MBBS,Anthony E. Maida III, PhD, MA, MBA,Sanjive Qazi, PhD,Kate-Lynn Muir, DO,Bhavina Sharma MD,Lynette Smith, PhD,Apar Kishor Ganti, MD

October 30th 2025

Unusual Clinical Presentation of Clear Cell Sarcoma in a Young Woman

BySamia Asif, MBBS,Brendan J. Hurley, MD,Sehr Haroon, MD,Subodh Lele, MD,Bhavina Sharma MD

October 12th 2023

A young woman presents with painless lumps to the emergency department and is later diagnosed with clear cell carcinoma.

Latest Updated Articles

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC
October 30th 2025
Unusual Clinical Presentation of Clear Cell Sarcoma in a Young Woman
October 12th 2023

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)

Cevostamab May Fill Gap in Multiple Myeloma Armamentarium